GO
Loading...

Celgene CEO on Health Care Growth

Thursday, 12 Apr 2012 | 3:20 PM ET

The S&P Biotech Index is up more than 10 percent and Celgene is one of its biggest gainers. Robert Hugin, Celgene chairman & CEO, discusses what's driving the company's growth, including its recent acquisition of Avila Therapeutics.